Skip to main content
Figure 3 | Experimental Hematology & Oncology

Figure 3

From: Effective long-term treatment with bevacizumab for relapsed glioblastoma: case report and review of the literature

Figure 3

Treatment response after 17 courses of bevacizumab in cMRI. A Non-enhanced T1-weighted MRI reveals further decrease in lesion size. Hyperintense hemorrhagic changes are present within the medial portion of the tumor. B Gadolinium-enhanced T1-weighted MRI documents lack of contrast enhancement in the lateral portions of the tumor. Only a slight enhancement in addition to the hyperintense hemorrhagic changes in the medial portion of the tumor was observed. C T2-weighted FLAIR demonstrates a decrease of peritumoral edema.

Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us